A record review study of poisoning deaths from forensic autopsy cases conducted at a tertiary center in Bangalore, India
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - Ongoing
Project Lead
Dr Marilyn
Authors
Dr Marilyn, Dr Rajan, Dr Varghese, Dr Sanjay Sukumar
Project Status
ongoing